See this page online at: http://www.biotechfocus.com/2006issue3
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
March 02 2006
The Next Step By Amber Lepage-Monette In December 2005, Cita NeuroPharmaceuticals Inc. (Mississauga, ON) was acquired by Winnersh, U.K.-based Vernalis - yet another example of the frequently seen cross-border M&A deal.
|
|
March 02 2006
Pain Points In Clinical Trials By Dr. David G. Barnes and Khaled El Emam, PhD For small- to medium-sized companies with investors and shareholders to please, there is a tendency to set very aggressive clinical trial milestones - a necessity in a competitive climate that carries with it substantial risks.
|
|
March 02 2006
Levelling The Playing Field By Kristine Archer They say money makes the world go around - and most researchers would be hard pressed to disagree.
|
|
March 02 2006
Uncommon Cents By Peter Colbourne Whether its buildings or relationships, the best approach to any task is to invest in a solid foundation at the outset.
|